Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - danazol 200 mg - capsules - danazol - treatment of endometriosis amenable to hormonal management, hereditary angioedema.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - alfuzosin hydrochloride 2.5 mg - tablets - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, notably when surgery has to be delayed for whaterver reason and during episodes of severe symptoms of adenoma, especially in elderly patients.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - cefotaxime as sodium 1 g - powder for solution for inj/inf - cefotaxime - severe infections caused by cefotaxime - sensitive pathogens : infections of the respiratory tract of the kidneys and urinary tract of the skin and soft tissues of the bones and joints of the genital organs including gonorrhoea and of the abdominal region. sepsis endocarditis meningitis. for preoperative prophylaxis in patients who are at increased risk from infection. for the prophylaxis of infections in patients with reduced resistance.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - spiramycin 1.5 miu - film coated tablets - spiramycin - respiratory tract infections, infections caused by clamydia, cryptosporidiosis pregnancy toxoplasmosis.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - ofloxacin 200 mg - film coated tablets - ofloxacin - for the treatment of bacterial infections if these are due to ofloxacin sensitive pathogens.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - teicoplanin - אבקה להכנת תמיסה לזריקה - teicoplanin 200 mg - teicoplanin - teicoplanin - for treatment of potentially serious gram-positive infections including those which cannot be treated with other antimicrobial drugs e.g.penicillins and cephalosporins.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - metronidazole 250 mg - film coated tablets - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - fludarabine phosphate 50 mg/vial - powder for solution for inj/inf - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludara is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - clofarabine 1 mg/ml - concentrate for solution for infusion - clofarabine - treatment of acute lymphoblastic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .

Israel - Ibrani - Ministry of Health

sanofi - aventis israel ltd - lenograstim 33.6 miu/ml - lyophilized powder for injection - lenograstim - - reduction in duration of neutropenia and associated complications in patients undergoing bone marrow transplantation or cytotoxic chemotherapy associated with a febrile neutropenia. - autologous mobilization of peripheral blood progenitor cells. as an adjunct to allogenic mobilization of peripheral blood progenitor cells (pbpcs).